Drug Shortage Report for MINESTRIN 1/20
Report ID | 130398 |
Drug Identification Number | 00343838 |
Brand name | MINESTRIN 1/20 |
Common or Proper name | Minestrin |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NORETHINDRONE ACETATE ETHINYL ESTRADIOL |
Strength(s) | 1MG 20MCG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 5x28 |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-01-01 |
Actual start date | 2021-01-01 |
Estimated end date | 2021-02-20 |
Actual end date | 2021-02-05 |
Shortage status | Resolved |
Updated date | 2021-02-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-02-06 | English | Compare |
v7 | 2021-02-05 | French | Compare |
v6 | 2021-02-05 | English | Compare |
v5 | 2021-01-13 | French | Compare |
v4 | 2021-01-13 | English | Compare |
v3 | 2021-01-02 | English | Compare |
v2 | 2020-12-18 | French | Compare |
v1 | 2020-12-18 | English | Compare |
Showing 1 to 8 of 8